Skip to main content
Top

Journal of Gastrointestinal Cancer

Issue 1/2005

Content (7 Articles)

Review

State of the art: Gastrointestinal malignancies in the human immunodeficiency virus (HIV) population

Mary Koshy, John Kauh, Clifford Gunthel, Melissa Joyner, Jerome Landry, Charles R. Thomas Jr.

Research Article

Induction of apoptosis and cell cycle arrest by imexon in human pancreatic cancer cell lines

Robert T. Dorr, Mary Ann Raymond, Terry H. Landowski, Nicholas O. Roman, Shoji Fukushima

Research Article

Prognostic factors in patients with colorectal cancer receiving adjuvant chemotherapy or chemoradiotherapy

Aristotle Bamias, George Basdanis, Ioannis Xanthakis, Nicholas Pavlidis, George Fountzilas

Research Article

Aberrant expression of maspin in idiopathic inflammatory bowel disease is associated with disease activity and neoplastic transformation

Dengfeng Cao, Robb E. Wilentz, James L. Abbruzzese, Linus Ho, Anirban Maitra

Research Article

Aberrant p16 methylation, a possible epigenetic risk factor in familial esophageal squamous cell carcinoma

Mohammad Reza Abbaszadegan, Hamid Reza Raziee, Kamran Ghafarzadegan, Mohammad Taghi Shakeri, Sima Afsharnezhad, Mohammad Reza Ghavamnasiry

Comment

Metastasis to appendix from lung adenocarcinoma

Kunihiko Miyazaki, Hiroaki Satoh, Kiyohisa Sekizawa

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.